Hiscox stock climbed 1.5% in today’s session, trading at 1,804.37p as markets absorbed the company’s half-year 2026 earnings update. The share price recovery followed an intraday low of 1,769p and left the stock trading well above its 52-week low of 1,258p and within reach of its 52-week high of 1,904p.
Results and guidance
The company reported first-half insurance contract written premium of $3.24 billion, up from $2.94 billion a year earlier. Alongside that top-line movement, Hiscox lifted its full-year retail business growth forecast to 9% from the prior 8% estimate.
Analyst stance and capital actions
JPMorgan reiterated an Overweight recommendation on Hiscox and maintained a GBP 20.50 price target on the shares. The bank characterised recent claims as largely idiosyncratic rather than signs of a structural deterioration, a view that helped temper investor concern.
Market participants also pointed to Hiscox’s active $300 million share buyback programme as supportive. The company has completed 18% of that programme as of its Q1 update, a factor that contributed to technical support for the shares and encouraged some investors to buy the dip.
Market backdrop
The broader session provided a constructive environment. FTSE 100 futures indicated an expected gain of about 0.3% at the open. Reports of progress in U.S.-Iran negotiations and an easing of related geopolitical tensions were cited as easing risk sentiment, while a positive overnight session on Wall Street and a lower oil price helped lift risk appetite across London markets.
Takeaway
The combination of a known earnings miss, a firm analyst endorsement from JPMorgan, tangible capital return via the buyback programme and an improved market tone across the FTSE 100 allowed Hiscox to recover from earlier weakness and trade meaningfully higher on the day. The stock now sits substantially above its 52-week low and within range of its 52-week high as investors weigh the company’s H1 metrics and the technical cushion provided by the buyback.